Cronos Group Reports Dismal Q4 Financial Results
Cronos Group Inc. (CRON), a constituent in the munKNEE Pure-Play Pot Stock Index, reported dismal Q4 financials for the period ending December 31, 2020, today, as follows:
Q4 Financial Highlights (All figures are in U.S. Dollars and compared to the previous quarter)
- Revenue: increased 4.9% to $17.0M
- Gross Profit (Loss) ($): loss increased by 89.0% to $(14.9)M
- Gross Profit (%): unchanged @ (14)%
- Adj. EBITDA Profit (Loss): loss increased 31.8% to $(53.1)M
Operational Highlights
- Natuera, a fully licensed joint venture operation in Colombia for hemp and cannabis-derived bulk, completed its first export of hemp-derived CBD extract to the U.S. for commercial purposes
Stock Performance
Cronos' stock price went up 38.5% during the October through December 2020 time period as seen in the chart below and had advanced a further 55.5% as of yesterday before declining today in response to its dismal Q4 results.
Visit munKNEE.com and register to receive our free Market Intelligence Report newsletter (sample more
How did you like this article? Let us know so we can better customize your reading experience.
An interesting post, but what is missing is any conclusion as to what was the cause of those "Dismal 4Q results", after such an encouraging rise. Only rarely do things just happen with no cause, and so some analysis could have been quite educational, or at least interesting.